BHST

BioHarvest's platform technology can produce various plant-based compounds with applications spanning nutraceuticals, functional foods, cosmetics, and potentially pharmaceuticals. The company's lead commercial product is VINIA, a powdered dietary supplement derived from red grape cells containing high concentrations of polyphenols and other bioactive compounds associated with cardiovascular health benefits. VINIA exemplifies the company's ability to produce botanically identical compounds to those found in grapes but with higher concentrations and consistency. BioHarvest markets VINIA directly to consumers through e-commerce and retail distribution.

The company's technology platform extends beyond VINIA to potentially produce other high-value botanical compounds including cannabinoids, medicinal plant extracts, rare natural products, and compounds that are difficult or expensive to obtain through traditional cultivation. BioHarvest's cell culture approach offers advantages including year-round production, no agricultural inputs (pesticides, herbicides), no weather-dependent risks, scalability through bioreactor capacity additions, and consistent product quality. The company continues advancing its product pipeline, scaling commercial operations, expanding distribution, and exploring applications of its platform across various industries. Success depends on demonstrating consumer demand for its products, achieving production cost competitiveness, establishing distribution partnerships, and protecting intellectual property around its cultivation technology and products.